Abstract:Although most pathogens infect the human body via mucosal surfaces, very few injectable vaccines can specifically target immune cells to these tissues where their effector functions would be most desirable. We have previously shown that certain adjuvants can program vaccine-specific helper T cells to migrate to the gut, even when the vaccine is delivered non-mucosally. It is not known whether this is true for antigen-specific B cell responses. Here we show that a single intradermal vaccination with the adjuvan… Show more
“…This is particularly true in the case of adjuvants that can target mucosal tissues with appropriate immune responses. For example, it is known that the ADP-ribosylating adjuvant double mutant heat labile toxin (dmLT) can drive both antigen specific T and B cells into mucosal tissues such as the lung and gut [ 101 , 102 ]. This is true even when the dmLT adjuvanted vaccine was delivered non-mucosally.…”
Section: Conclusion and Future Vaccine Effortsmentioning
“…This is particularly true in the case of adjuvants that can target mucosal tissues with appropriate immune responses. For example, it is known that the ADP-ribosylating adjuvant double mutant heat labile toxin (dmLT) can drive both antigen specific T and B cells into mucosal tissues such as the lung and gut [ 101 , 102 ]. This is true even when the dmLT adjuvanted vaccine was delivered non-mucosally.…”
Section: Conclusion and Future Vaccine Effortsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.